Literature DB >> 6277909

Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight.

W J Schneider, U Beisiegel, J L Goldstein, M S Brown.   

Abstract

This paper describes a rapid two-step procedure for the purification of the low density lipoprotein receptor from bovine adrenal cortex membranes. After solubilization with nonionic detergents, the receptor adheres tightly to a DEAE-cellulose column at pH 6. Following elution from DEAE-cellulose, detergent is removed, leaving the receptor in a soluble form. The receptor is then subjected to affinity chromatography on low density lipoprotein coupled to Sepharose 4B. The receptor is eluted with suramin, a newly-found inhibitor of low density lipoprotein-receptor interactions. This procedure yields a single protein with a molecular weight of 164,000. The same protein is also isolated when the crude DEAE-cellulose fraction is applied to an immunoaffinity column containing a monoclonal antibody directed against the receptor. The 164,000-dalton receptor protein has an acidic isoelectric point of 4.6, which rises to 4.8 after extensive treatment with neuraminidase. The purified receptor retains all of the binding properties of the receptor of intact cells and crude membranes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277909

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease.

Authors:  Sascha N Goonewardena
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

2.  Characterization of the binding of human low-density lipoprotein to primary monolayer cultures of rat hepatocytes.

Authors:  A M Salter; J Saxton; D N Brindley
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

3.  A single chicken oocyte plasma membrane protein mediates uptake of very low density lipoprotein and vitellogenin.

Authors:  S Stifani; D L Barber; J Nimpf; W J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Detection of the low-density-lipoprotein receptor with biotin-low-density lipoprotein. A rapid new method for ligand blotting.

Authors:  D P Wade; B L Knight; A K Soutar
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

5.  Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.

Authors:  E E Powell; P A Kroon
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 6.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

7.  Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease.

Authors:  U Francke; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 8.  Pathophysiology of human lipoprotein receptors: clinical consequences of a cellular defect.

Authors:  J Shepherd; C J Packard
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

9.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

10.  Use of monoclonal anti-receptor antibodies to probe the expression of the low density lipoprotein receptor in tissues of normal and Watanabe heritable hyperlipidemic rabbits.

Authors:  M Huettinger; W J Schneider; Y K Ho; J L Goldstein; M S Brown
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.